{"transactions":[{"id":1968224,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":115901,"kind":"person","name":"Monohon Ted","position":1,"cik":"0001606905","reported_name":"Monohon Ted","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer & VP"}}],"security":"Common Stock","published_at":"2023-03-06T18:55:56.000Z","date":"2023-03-06","kind":"sale","acquired":false,"shares":1871,"price":0.98,"value":1833.58,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold to satisfy tax withholding obligations that arose in connection with the vesting of 4,250 shares of Restricted Stock Units granted on March 3, 2022. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 23, 2022."}],"balance_after":27440,"source":{"system":"sec-edgar","filing":"0001209191-23-016507","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1606905/000120919123016507/doc4.xml","form_type":"4"}},{"id":2035090,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":115901,"kind":"person","name":"Monohon Ted","position":1,"cik":"0001606905","reported_name":"Monohon Ted","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer & VP"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-02-02T18:32:36.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in equal monthly installments, at a rate of 1/48th of the total number of shares on each monthly anniversary of the vesting commencement date of January 1, 2023, such that the total number of shares shall be fully vested on the four-year anniversary of the vesting commencement date."}],"balance_after":110000,"derivative":{"exercise_price":0.94,"expiration_date":"2033-01-31","underlying":"Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001209191-23-006398","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1606905/000120919123006398/doc4.xml","form_type":"4"}},{"id":2092970,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":115901,"kind":"person","name":"Monohon Ted","position":1,"cik":"0001606905","reported_name":"Monohon Ted","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer & VP"}}],"security":"Common Stock","published_at":"2022-12-07T17:37:47.000Z","date":"2022-12-05","kind":"tax_withholding","acquired":false,"shares":1640,"price":0.72,"value":1180.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold to satisfy tax withholding obligations that arose in connection with the vesting of 4,250 shares of Restricted Stock Units granted on March 3, 2022. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 23, 2022."}],"balance_after":29311,"source":{"system":"sec-edgar","filing":"0001209191-22-060218","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1606905/000120919122060218/doc4.xml","form_type":"4"}},{"id":2162979,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":115901,"kind":"person","name":"Monohon Ted","position":1,"cik":"0001606905","reported_name":"Monohon Ted","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer & VP"}}],"security":"Common Stock","published_at":"2022-09-08T17:58:12.000Z","date":"2022-09-06","kind":"tax_withholding","acquired":false,"shares":1520,"price":1.64,"value":2492.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold to satisfy tax withholding obligations that arose in connection with the vesting of 4,250 shares of Restricted Stock Units granted on March 3, 2022. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 23, 2022."}],"balance_after":30951,"source":{"system":"sec-edgar","filing":"0001209191-22-049221","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1606905/000120919122049221/doc4.xml","form_type":"4"}},{"id":2216727,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":115901,"kind":"person","name":"Monohon Ted","position":1,"cik":"0001606905","reported_name":"Monohon Ted","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer & VP"}}],"security":"Stock Option (right to buy)","published_at":"2022-07-01T17:03:16.000Z","date":"2022-06-29","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in 48 equal monthly installments from the vesting commencement date."}],"balance_after":250000,"derivative":{"exercise_price":2.26,"expiration_date":"2032-06-28","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001209191-22-040306","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1606905/000120919122040306/doc4.xml","form_type":"4"}},{"id":2238682,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":115901,"kind":"person","name":"Monohon Ted","position":1,"cik":"0001606905","reported_name":"Monohon Ted","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer & VP"}}],"security":"Common Stock","published_at":"2022-06-08T16:13:43.000Z","date":"2022-06-06","kind":"tax_withholding","acquired":false,"shares":1529,"price":3.12,"value":4770.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represent shares sold to satisfy tax withholding obligations that arose in connection with the vesting of 4,250 shares of Restricted Stock Units granted on March 3, 2022.  The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 23, 2022."}],"balance_after":32471,"source":{"system":"sec-edgar","filing":"0001209191-22-035020","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1606905/000120919122035020/doc4.xml","form_type":"4"}},{"id":2349591,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":115901,"kind":"person","name":"Monohon Ted","position":1,"cik":"0001606905","reported_name":"Monohon Ted","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer & VP"}}],"security":"Common Stock","published_at":"2022-03-04T17:58:51.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of Restricted Stock Units (the \"RSU Award\") payable solely in common stock of the Issuer.  The shares subject to the RSU Award shall vest in equal quarterly installments over two years, with 1/8th of the total number of shares subject to the RSU Award vesting on each quarterly anniversary of the date of grant."}],"balance_after":34000,"source":{"system":"sec-edgar","filing":"0001209191-22-016443","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1606905/000120919122016443/doc4.xml","form_type":"4"}},{"id":2442779,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":115901,"kind":"person","name":"Monohon Ted","position":1,"cik":"0001606905","reported_name":"Monohon Ted","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-05T16:39:33.000Z","date":"2021-12-14","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in 48 equal monthly installments from the vesting commencement date."}],"balance_after":50000,"derivative":{"exercise_price":11.35,"expiration_date":"2031-12-13","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-22-001731","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1606905/000120919122001731/doc4.xml","form_type":"4"}},{"id":2865727,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":115901,"kind":"person","name":"Monohon Ted","position":1,"cik":"0001606905","reported_name":"Monohon Ted","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-02-11T21:21:24.000Z","date":"2021-02-09","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the total number of shares subject to the Option shall vest and become exercisable on each monthly anniversary of the vesting start date (and if there is no corresponding day, the last day of the month)."}],"balance_after":20000,"derivative":{"exercise_price":46.1,"expiration_date":"2031-02-08","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-21-009949","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1606905/000120919121009949/doc4.xml","form_type":"4"}}]}